Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1

Allison B. Weisbrod, Naris Nilubol, Lee S. Weinstein, William F. Simonds, Steven K. Libutti, Robert T. Jensen, Stephen J. Marx, Electron Kebebew

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Context: The ABO blood type system describes the expression of human blood group antigens found on both erythrocytes and normal tissue throughout the body. We recently reported an association between O blood type and the manifestation of pancreatic neuroendocrine tumors in a cohort of patients with Von Hippel-Lindau syndrome. Objective: The aim of the study was to determine whether there is an association of ABO blood type with the development of neuroendocrine tumors in patients with multiple endocrine neoplasia, type 1 (MEN-1). Design: Aretrospective analysis of 105 patients with MEN-1 was performed. Demographic, clinical, and biochemical data were analyzed by ABO blood type. Fisher's exact test was used to determine association between ABO blood type and manifestation of neuroendocrine tumor. Results: Demographic and clinical characteristics were similar amongst blood type cohorts. We found an association between O blood type and the manifestation of a primary neuroendocrine tumor of the gastrointestinal tract, lung, pancreas, and thymus in patients with MEN-1 (P = 0.01). Sixteen of 17 (94%) metastatic tumors had type-O blood, compared to 32 of 43 (74%) with a benign tumor who had non-O blood type. Conclusions: Our findings suggest an association between O blood type and the manifestation of a primary neuroendocrine tumor in patients with MEN-1. Prospective clinical studies are warranted to see whether patient blood type status may be a useful addition to current screening and surveillance practices.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Multiple Endocrine Neoplasia Type 1
Neuroendocrine Tumors
Tumors
Blood
Demography
von Hippel-Lindau Disease
Thymus
Blood Group Antigens
Thymus Gland
Gastrointestinal Tract
Pancreas
Neoplasms
Screening
Erythrocytes

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Weisbrod, A. B., Nilubol, N., Weinstein, L. S., Simonds, W. F., Libutti, S. K., Jensen, R. T., ... Kebebew, E. (2013). Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism, 98(1). https://doi.org/10.1210/jc.2012-2781

Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. / Weisbrod, Allison B.; Nilubol, Naris; Weinstein, Lee S.; Simonds, William F.; Libutti, Steven K.; Jensen, Robert T.; Marx, Stephen J.; Kebebew, Electron.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 1, 01.2013.

Research output: Contribution to journalArticle

Weisbrod, AB, Nilubol, N, Weinstein, LS, Simonds, WF, Libutti, SK, Jensen, RT, Marx, SJ & Kebebew, E 2013, 'Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1', Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 1. https://doi.org/10.1210/jc.2012-2781
Weisbrod, Allison B. ; Nilubol, Naris ; Weinstein, Lee S. ; Simonds, William F. ; Libutti, Steven K. ; Jensen, Robert T. ; Marx, Stephen J. ; Kebebew, Electron. / Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. In: Journal of Clinical Endocrinology and Metabolism. 2013 ; Vol. 98, No. 1.
@article{34fa1534418a471fb405cd1029115b8a,
title = "Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1",
abstract = "Context: The ABO blood type system describes the expression of human blood group antigens found on both erythrocytes and normal tissue throughout the body. We recently reported an association between O blood type and the manifestation of pancreatic neuroendocrine tumors in a cohort of patients with Von Hippel-Lindau syndrome. Objective: The aim of the study was to determine whether there is an association of ABO blood type with the development of neuroendocrine tumors in patients with multiple endocrine neoplasia, type 1 (MEN-1). Design: Aretrospective analysis of 105 patients with MEN-1 was performed. Demographic, clinical, and biochemical data were analyzed by ABO blood type. Fisher's exact test was used to determine association between ABO blood type and manifestation of neuroendocrine tumor. Results: Demographic and clinical characteristics were similar amongst blood type cohorts. We found an association between O blood type and the manifestation of a primary neuroendocrine tumor of the gastrointestinal tract, lung, pancreas, and thymus in patients with MEN-1 (P = 0.01). Sixteen of 17 (94{\%}) metastatic tumors had type-O blood, compared to 32 of 43 (74{\%}) with a benign tumor who had non-O blood type. Conclusions: Our findings suggest an association between O blood type and the manifestation of a primary neuroendocrine tumor in patients with MEN-1. Prospective clinical studies are warranted to see whether patient blood type status may be a useful addition to current screening and surveillance practices.",
author = "Weisbrod, {Allison B.} and Naris Nilubol and Weinstein, {Lee S.} and Simonds, {William F.} and Libutti, {Steven K.} and Jensen, {Robert T.} and Marx, {Stephen J.} and Electron Kebebew",
year = "2013",
month = "1",
doi = "10.1210/jc.2012-2781",
language = "English (US)",
volume = "98",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1

AU - Weisbrod, Allison B.

AU - Nilubol, Naris

AU - Weinstein, Lee S.

AU - Simonds, William F.

AU - Libutti, Steven K.

AU - Jensen, Robert T.

AU - Marx, Stephen J.

AU - Kebebew, Electron

PY - 2013/1

Y1 - 2013/1

N2 - Context: The ABO blood type system describes the expression of human blood group antigens found on both erythrocytes and normal tissue throughout the body. We recently reported an association between O blood type and the manifestation of pancreatic neuroendocrine tumors in a cohort of patients with Von Hippel-Lindau syndrome. Objective: The aim of the study was to determine whether there is an association of ABO blood type with the development of neuroendocrine tumors in patients with multiple endocrine neoplasia, type 1 (MEN-1). Design: Aretrospective analysis of 105 patients with MEN-1 was performed. Demographic, clinical, and biochemical data were analyzed by ABO blood type. Fisher's exact test was used to determine association between ABO blood type and manifestation of neuroendocrine tumor. Results: Demographic and clinical characteristics were similar amongst blood type cohorts. We found an association between O blood type and the manifestation of a primary neuroendocrine tumor of the gastrointestinal tract, lung, pancreas, and thymus in patients with MEN-1 (P = 0.01). Sixteen of 17 (94%) metastatic tumors had type-O blood, compared to 32 of 43 (74%) with a benign tumor who had non-O blood type. Conclusions: Our findings suggest an association between O blood type and the manifestation of a primary neuroendocrine tumor in patients with MEN-1. Prospective clinical studies are warranted to see whether patient blood type status may be a useful addition to current screening and surveillance practices.

AB - Context: The ABO blood type system describes the expression of human blood group antigens found on both erythrocytes and normal tissue throughout the body. We recently reported an association between O blood type and the manifestation of pancreatic neuroendocrine tumors in a cohort of patients with Von Hippel-Lindau syndrome. Objective: The aim of the study was to determine whether there is an association of ABO blood type with the development of neuroendocrine tumors in patients with multiple endocrine neoplasia, type 1 (MEN-1). Design: Aretrospective analysis of 105 patients with MEN-1 was performed. Demographic, clinical, and biochemical data were analyzed by ABO blood type. Fisher's exact test was used to determine association between ABO blood type and manifestation of neuroendocrine tumor. Results: Demographic and clinical characteristics were similar amongst blood type cohorts. We found an association between O blood type and the manifestation of a primary neuroendocrine tumor of the gastrointestinal tract, lung, pancreas, and thymus in patients with MEN-1 (P = 0.01). Sixteen of 17 (94%) metastatic tumors had type-O blood, compared to 32 of 43 (74%) with a benign tumor who had non-O blood type. Conclusions: Our findings suggest an association between O blood type and the manifestation of a primary neuroendocrine tumor in patients with MEN-1. Prospective clinical studies are warranted to see whether patient blood type status may be a useful addition to current screening and surveillance practices.

UR - http://www.scopus.com/inward/record.url?scp=84872057743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872057743&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-2781

DO - 10.1210/jc.2012-2781

M3 - Article

C2 - 23093487

AN - SCOPUS:84872057743

VL - 98

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -